Loading...

Michele Tana, MD

TitleAssistant Professor
SchoolUCSF School of Medicine
DepartmentMedicine
Address1001 Potrero Avenue 3D
San Francisco CA 94110
Phone415-206-8823
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Harvard CollegeA.B.2000Classics
    Harvard UniversityM.D.2005Medical Schoool
    Duke UniversityM.H.S.2016Clinical Research
    Stanford UniversityInternal Medicine2008School of Medicine
    California Pacific Medical CenterGastroenterology2011Department of Medicine
    National Institutes of HealthHepatology2013NIDDK

    Collapse Overview 
    Collapse Overview
    Michele Tana grew up in Northern Virginia. She studied the Classics at Harvard College, then went to Harvard Medical School. She did her Internal Medicine training at Stanford University Hospital and Clinics and her gastroenterology fellowship at California Pacific Medical Center. She spent two years at the National Institutes of Health as a Clinical Fellow in the National Institute of Diabetes and Digestive and Kidney Diseases, Liver Diseases Branch, then joined the UCSF faculty at San Francisco General Hospital in 2013. She is a clinician-educator with an interest in clinical research.


    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. van Wijk XM, Magee CA, Wu AH, Tana M, Lynch KL. A comparison of methods for evaluation of a case of suspected macro-aspartate aminotransferase. Clin Chim Acta. 2016 Oct 11; 463:1-3. PMID: 27732874.
      View in: PubMed
    2. Ha J, Yan M, Aguilar M, Bhuket T, Tana M, Liu B, Gish RG, Wong RJ. Race/ethnicity-specific disparities in cancer incidence, burden of disease, and overall survival among patients with hepatocellular carcinoma in the United States. Cancer. 2016 Aug 15; 122(16):2512-23. PMID: 27195481.
      View in: PubMed
    3. Ha J, Yan M, Aguilar M, Tana M, Liu B, Frenette CT, Bhuket T, Wong RJ. Race/Ethnicity-specific Disparities in Hepatocellular Carcinoma Stage at Diagnosis and its Impact on Receipt of Curative Therapies. J Clin Gastroenterol. 2016 May-Jun; 50(5):423-30. PMID: 26583267.
      View in: PubMed
    4. Tana M, Shums Z, Milo J, Norman GL, Leung PS, Gershwin ME, Noureddin M, Kleiner DE, Zhao X, Heller T, Hoofnagle JH. The Significance of Autoantibody Changes Over Time in Primary Biliary Cirrhosis. Am J Clin Pathol. 2015 Oct; 144(4):601-6. PMID: 26386081.
      View in: PubMed
    5. Tana M, Zhao X, Bradshaw A, Moon MS, Page S, Turner T, Rivera E, Kleiner DE, Heller T. Factors associated with the platelet count in patients with chronic hepatitis C. Thromb Res. 2015 May; 135(5):823-8. PMID: 25728497; PMCID: PMC4414791 [Available on 05/01/16].
    6. Tana M, Heller T. Autoantibodies in hepatitis C: red flag or bystander effect? J Pediatr Gastroenterol Nutr. 2013 Mar; 56(3):243. PMID: 23443062; PMCID: PMC3584299.
    7. Tana M, Hoofnagle JH. Scar undone: long-term therapy of hepatitis B. Lancet. 2013 Feb 9; 381(9865):433-4. PMID: 23234726.
      View in: PubMed
    Michele's Networks
    Concepts
    Derived automatically from this person's publications.
    _
    Co-Authors
    People in Profiles who have published with this person.
    _
    Related Authors
    People who share related concepts with this person.
    _
    Back to TOP